Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 402

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 4
Chunk 402
---
 directors considers educational background, diversity of professional experience, knowledge of our
business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.
Prior to our initial business combination, holders of our public shares will not have the right to recommend director candidates for nomination
to our board of directors.

Compensation Committee Interlocks and Insider Participation

None of our officers currently serves, and in
the past year has not served, (i) as a member of the compensation committee or board of directors of another entity, one of whose executive
officers served on our compensation committee, or (ii) as a member of the compensation committee of another entity, one of whose executive
officers served on our board of directors.

Director Nominations

We do not have a standing nominating committee,
though we intend to form a corporate governance and nominating committee as and when required to do so by law or Nasdaq listing rules.
In accordance with Rule 5605(e)(1)(A) of the Nasdaq listing rules, a majority of the independent directors may recommend a director
nominee for selection by the board of directors. The board of directors believes that the independent directors can satisfactorily carry
out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee.
As there is no standing nominating committee, we do not have a nominating committee charter in place.

Our independent directors will recommend to the
board of directors candidates for nomination for election at the annual general meeting of the shareholders. The board of directors will
also consider director candidates recommended for nomination by holders of our ordinary shares during such times as they are seeking proposed
nominees to stand for appointment at an annual general meeting (or, if applicable, an extraordinary general meeting). Our shareholders
that wish to nominate a director for election to the board of directors should follow the procedures set forth in our amended and restated
memorandum and articles of association.

We have not formally established any specific,
minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating
nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our
business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.

Clawback Policy

We have adopted a compensation recovery policy
that is compliant with Nasdaq listing rules as required by the Dodd-Frank